Latest Balaxi Pharmaceuticals stock price
Balaxi Pharmaceuticals P/E Ratio
BALAXI • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
10.06
Low Valuation
Low - May indicate good value opportunity
Current Valuation Metrics
P/E Ratio
10.06
Current Price
₹25.44
EPS (TTM)
₹4.54
Exchange
NSE
Valuation Signal
Signal
Undervalued
Historical Avg
2.53
Historical Range
0.5 - 6.5
Percentile
100.0%
Sector Context
Sector Average
53.73
Sector Median
31.12
Sector Rank
#7 of 131
Sector Percentile
5.3%
Earnings Breakdown (TTM)
TTM EPS
₹2.49
Sept 2025
₹0.04
Mar 2025
₹1.56
Key P/E Ratio Insights for Balaxi Pharmaceuticals
- Stock appears undervalued with PE of 10.06, suggesting potential buying opportunity
- Current PE is 297.3% above historical average
- Trading at discount to sector average PE of 53.73
View the BALAXI equity price for detailed stock performance.
P/E Ratio Historical Trend for Balaxi Pharmaceuticals
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for Balaxi Pharmaceuticals
Additional stock information and data for BALAXI
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 6.5 | 13.39 | ₹87.10 | NSE | Low |
| 2022 | 2.05 | 50.56 | ₹103.55 | NSE | Low |
| 2021 | 2.96 | 43.3 | ₹128.25 | NSE | Low |
| 2020 | 0.5 | 31.23 | ₹15.75 | NSE | Low |
| 2019 | 0.65 | 9.26 | ₹6.00 | NSE | Low |
Sector P/E Ratio Comparison
Comparing Balaxi Pharmaceuticals with other companies in Healthcare sector
Sector Average
53.73
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |